E For L Aim PCL (BKK:EFORL-F) Risk Assessment

View and export this data going back to 2009. Start your Free Trial

What is E For L Aim PCL Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of E For L Aim PCL is: No Data: Cannot be evaluated.

Competitive Comparison of E For L Aim PCL's Risk Assessment

For the Medical Distribution subindustry, E For L Aim PCL's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

E For L Aim PCL's Risk Assessment Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, E For L Aim PCL's Risk Assessment distribution charts can be found below:

* The bar in red indicates where E For L Aim PCL's Risk Assessment falls into.

E For L Aim PCL (BKK:EFORL-F) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

E For L Aim PCL Risk Assessment Related Terms

Thank you for viewing the detailed overview of E For L Aim PCL's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

E For L Aim PCL (BKK:EFORL-F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » E For L Aim PCL (BKK:EFORL-F) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

EFORL:Thailand

Address

No. 432 Rajavithi Road, Bangyee Khan Sub District, Bangplad District, Bangkok, THA, 10700

Website

https://www.eforl-aim.com

E For L Aim PCL operates as a dealer and importer of medical devices and equipment and provides advertising services. It serves customers in both the government and private sectors. The company and subsidiaries' business operations involve two principle segments which are Distributor of medical devices and equipment; and Beauty treatment segments. In addition, the group is also involved providing advertising services. Geographically all the operations are carried out through the region of Thailand. The Distributor of medical devices and equipment act as a key revenue driver for the firm.

E For L Aim PCL (BKK:EFORL-F) Headlines

No Headlines